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Pseudomonas aeruginosa is a pathogenic Gram-negative bacterium that causes severe opportunistic infections
in immunocompromised individuals; in particular, severity of infection with P. aeruginosa positively correlates
with poor prognosis in cystic fibrosis (CF) patients. Establishment of chronic infection by this pathogen is
associated with downregulation of flagellar expression and of other genes that regulate P. aeruginosa motility.
The current paradigm is that loss of flagellar expression enables immune evasion by the bacteria due to loss
of engagement by phagocytic receptors that recognize flagellar components and loss of immune activation
through flagellin-mediated Toll-like receptor (TLR) signaling. In this work, we employ bacterial and mam-
malian genetic approaches to demonstrate that loss of motility, not the loss of the flagellum per se, is the critical
factor in the development of resistance to phagocytosis by P. aeruginosa. We demonstrate that isogenic P.
aeruginosa mutants deficient in flagellar function, but retaining an intact flagellum, are highly resistant to
phagocytosis by both murine and human phagocytic cells at levels comparable to those of flagellum-deficient
mutants. Furthermore, we show that loss of MyD88 signaling in murine phagocytes does not recapitulate the
phagocytic deficit observed for either flagellum-deficient or motility-deficient P. aeruginosa mutants. Our data
demonstrate that loss of bacterial motility confers a dramatic resistance to phagocytosis that is independent
of both flagellar expression and TLR signaling. These findings provide an explanation for the well-documented
observation of nonmotility in clinical P. aeruginosa isolates and for how this phenotype confers upon the
bacteria an advantage in the context of immune evasion.
Pseudomonas aeruginosa is an opportunistic Gram-negative
bacterial pathogen that causes severe infections in immuno-
compromised patients and in the pulmonary compartment of
patients suffering from cystic fibrosis (CF) (13, 14). In CF
patients, disease severity is positively correlated with coloniza-
tion by P. aeruginosa and the establishment of chronic infec-
tion. As part of the colonization process, the bacteria undergo
a number of genetic changes that assist in their ability to
survive in the mammalian host and to evade detection and
clearance by the immune system (9, 21). One such change that
has been phenotypically characterized for P. aeruginosa is loss
of flagellar motility (12, 17). Furthermore, the loss of flagellar
gene expression and motility function is associated with in-
creased bacterial burdens and increased disease severity in CF
patients (12, 17). While downregulation of flagellar expression
has been inferred to confer a survival advantage on P. aerugi-
nosa once it colonizes the host by evasion of both phagocytic
receptors and TLR5-driven inflammatory signaling, the exact
contribution of flagellum downregulation with respect to suc-
cessful immune evasion is unclear (5, 17, 18).
Nonopsonic phagocytosis of P. aeruginosa by murine and
human macrophages has previously been reported to require
the expression of a flagellum, and the interpretation of these
results concluded that the flagellum is a necessary ligand for
triggering phagocytic internalization of the bacteria (18). Fur-
thermore, flagellar expression is reported to be critical for
inducing inflammation during P. aeruginosa infection, and loss
of flagellar gene expression results in impaired inflammatory
responses and attenuated bacterial clearance (5). Here, we
provide data that challenge the current paradigm that the
flagellum functions as a primary phagocytic ligand for P.
aeruginosa ingestion by immune cells with the formal demon-
stration that motility, rather than loss of flagellar expression,
confers the advantage toward P. aeruginosa evasion of phago-
cytosis.
In these studies, we use P. aeruginosa motility-defective mu-
tants to assess the role of bacterial motility in regard to phago-
cytic recognition by innate immune cells. When present in an
aqueous environment, P. aeruginosa can swim via rotation of a
single polar, monotrichous flagellum (27); there is currently no
evidence that P. aeruginosa bacteria produce lateral flagella or
alter their cell morphology as a direct function of motility. For
the purposes of this report, motility refers to flagellum-based
bacterial movement in an aqueous environment unless specif-
ically indicated. Of note, P. aeruginosa is also capable of a
flagellum-independent type of motility termed twitching in
which type IV pilus filaments that extend from the cell body
adhere to a surface and then retract, thus propelling the bac-
terium forward (23). Bacterial flagellar motility occurs through
a motor complex that provides energy for rotational torque of
a helical filament of repeating flagellin subunits that act as a
propeller. The rotor, a multimer complex composed of FliG,
FliM, and FliN, acts as a molecular switch and determines
clockwise or counterclockwise rotation (27). In P. aeruginosa,
the stator complex, which provides a stationary housing for the
* Corresponding author. Mailing address: Department of Microbi-
ology and Immunology, Dartmouth Medical School, Lebanon, NH
03756. Phone: (603) 650-6899. Fax: (603) 650-6223. E-mail: berwin
@dartmouth.edu.
† Supplemental material for this article may be found at http://iai
.asm.org/.
‡ E.A. and R.R.L. contributed equally to this report.
 Published ahead of print on 10 May 2010.
2937
rotor, is composed of at least four partially redundant integral
membrane proteins, MotAB and MotCD. Deletion of all four
stators allows for flagellar assembly, but the structure cannot
rotate and so the mutant is nonmotile (swimming and swarm-
ing defective) (27).
Previous reports have concluded that an intact flagellum is
required for phagocytic recognition of P. aeruginosa (18). How-
ever, here we demonstrate that the phagocytic resistance ex-
hibited by swimming motility-defective bacteria is not due to
loss of flagellum-mediated activation of immune cells, since
bacteria expressing a nonfunctional flagellum exhibit phago-
cytic resistance comparable to that of flagellum-deficient bac-
teria and loss of MyD88 signaling in phagocytic cells does not
recapitulate this defect for phagocytosis. Rather, with the use
of a variety of in vitro, ex vivo, and in vivo infection models, we
show that loss of P. aeruginosa motility dramatically alters
immune responses to these bacteria compared to those for
motile isogenic bacterial strains and that it is the loss of fla-
gellum-mediated motility, but not flagellum expression itself,
that results in dramatic bacterial resistance to phagocytosis by
murine and human phagocytes. These studies provide an ex-
planation for the clinical observation that P. aeruginosa isolates
obtained from CF hosts often exhibit a nonmotile phenotype
and explain how this phenotype can confer a survival advan-
tage for bacteria that modulate or lose their motility during an
active infection.
MATERIALS AND METHODS
Mice and cells. C57BL/6 wild-type (WT) mice were obtained from The Jack-
son Laboratory (Bar Harbor, ME). MyD88/ mice were generated by Adachi
et al. (1). The bone marrow-derived dendritic cell (BMDC) culture protocol used
is a modification of the work of Inaba et al. (11) as previously described (4). For
these studies, the Pseudomonas aeruginosa clinical isolate PA14 is the parental
bacterial strain and wild-type control for all of the isogenic mutants studied.
Human peripheral blood monocytes were a generous gift from the lab of Paul
Guyre (Dartmouth). Monocytes were differentiated into macrophages by cultur-
ing them in the presence of 10 g/ml granulocyte-macrophage colony-stimulating
factor (GM-CSF) for 7 days.
FACS-based bacterial association assay for GFP bacteria. Bacterial strains
expressing green fluorescent protein (GFP) were generated by transformation of
the indicated strains with a multicopy plasmid (pSMC21 Ampr Kanr Carbr
GFP) that constitutively expresses GFP under the control of a derivative of the
Ptac promoter (6, 15). C57BL/6 BMDCs were incubated with the indicated GFP
bacterial strains for 45 min at 37°C or 4°C, as indicated in the text. For bacterial
binding assays, BMDCs were preincubated in 10 M cytochalasin D (Sigma) in
serum-free Hanks balanced salt solution (HBSS) for 60 min at 37°C. Coincuba-
tion between BMDCs and the indicated GFP bacterial strains took place in the
presence of 10 M cytochalasin D for 45 min at 37°C. Cells were washed
thoroughly in serum-free HBSS and then analyzed by fluorescence-activated cell
sorting (FACS) for the acquisition of fluorescence as an indication of BMDC
association with the bacteria. The mean fluorescence intensities of the BMDC
populations were assessed and graphed to obtain relative efficiency of cellular
association with the different bacterial strains.
Microscopy. BMDCs from B6.Cg-Tg(CAG-mRFP1) mice (C57BL/6 back-
ground; purchased from Jackson Labs), which express red fluorescent protein
(RFP) from the actin promoter, were cultured as previously described (5). Cells
were coincubated with GFP-expressing P. aeruginosa strains as indicated for 45
min at 37°C at a multiplicity of infection (MOI) of 10. Cells were washed twice
in 400 l of serum-free HBSS prior to a 10-min cytospin onto glass slides at 1,000
rpm. Cells were visualized via fluorescence and differential interference contrast
(DIC) microscopy. Microscopy was performed on a Zeiss LSM510 Meta micro-
scope using a 63 lens, followed by image analysis on the LSM5 Image Browser
software.
Bacterial motility swimming assay. Bacterial motility was examined as de-
scribed elsewhere (7, 27). Briefly, 0.3% agar plates were poured and the indi-
cated bacterial strains were inoculated from liquid cultures onto the plates by
puncturing inoculates halfway through the depth of the agar. Plates were incu-
bated at room temperature for 48 h and monitored for the generation of bac-
terial halos as an indication of swimming motility. Plates were subsequently
photographed with a digital camera to allow comparison of the relative swim-
ming motilities of the different bacterial strains.
Western Blot analyses and Coomassie blue staining. Analysis of total flagellin
expression by the indicated bacterial strains was performed by lysis of the whole
bacteria in SDS sample buffer containing 5% -mercaptoethanol. Analysis of the
presence of extracellular flagella on the motAB motCD mutant was performed
as a modification of published methodology (19, 25). Briefly, a 100-ml culture of
bacteria was pelleted by centrifugation, resuspended in phosphate-buffered sa-
line (PBS), and sheared for 3 min in a blender. The sheared suspension was
centrifuged at 8,000  g for 10 min, and the protein within the supernatant was
subsequently precipitated with the addition of trichloroacetic acid (TCA) to
20%. The precipitated pellet was washed with acetone and resuspended in SDS
sample buffer containing 5% -mercaptoethanol. For both the bacterial lysates
and the isolated flagellin, the samples were boiled and separated on 12% SDS-
PAGE gels. Parallel lanes were used either for Coomassie blue staining or for
transfer onto Immobilon-P membranes (Millipore Corp.) for Western analysis.
Following blotting with polyclonal anti-FliC antibody (22), Western blots were
developed using enhanced chemiluminescence (ECL) (Amersham Biosciences)
of horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson Im-
munoresearch).
In vitro gentamicin protection assays. Phagocytosis of live P. aeruginosa bac-
teria was performed as a modified version of published protocols (4, 8) and as
previously described (2). Briefly, overnight cultures of P. aeruginosa were washed
and resuspended in serum-free medium and bacterial concentrations were de-
termined. BMDCs of the indicated genotype (2  105) were incubated with
bacteria at an MOI of 10 for 45 min at 37°C, followed by incubation in 100
g/ml gentamicin for 20 min at 37°C. For intracellular killing assays, a modifi-
cation of the previous protocol (3) was used: following a 1-h coincubation of
PA14 bacteria and BMDCs, gentamicin was added and, for the following 60 min,
aliquots were assayed as described above for remaining CFU. In all cases, cells
were washed and subsequently lysed in 500 l 0.1% Triton X-100 in PBS. Lysates
were plated onto Pseudomonas isolation agar and incubated overnight at 37°C.
The next day, colonies were counted and relative phagocytosis was determined
by CFU counts.
Ex vivo peritoneal phagocyte gentamicin protection assay and FACS analyses.
Phagocytosis of live P. aeruginosa bacteria was performed as a modified version
of previously described protocols (4, 8). Overnight cultures of P. aeruginosa were
washed twice in 1 ml serum-free HBSS and resuspended in 10 ml HBSS. Bac-
terial concentrations were determined based on estimated 1  109 CFU/ml
saturation levels. Naïve C57BL/6 mice were injected intraperitoneally (i.p.) with
1 ml of 4% thioglycolate and subsequently sacrificed 4 days later. The peritoneal
cavity was lavaged with 6 ml of serum-free HBSS. The lavage fluid was centri-
fuged, and pelleted cells were washed twice in serum-free HBSS before being
resuspended in 2 ml serum-free HBSS. For the gentamicin protection assay,
peritoneal phagocytes and bacteria were subsequently treated as described above
for in vitro gentamicin protection assays. Alternatively, peritoneal phagocytes
were coincubated with GFP-expressing bacteria for 45 min at 37°C. Cells were
washed twice in serum-free HBSS and resuspended in 250 l HBSS. Bacterial
association with phagocytes was determined via FACS analysis as described
previously.
Ex vivo lung phagocyte gentamicin protection assay and FACS analyses.
Phagocytosis of live P. aeruginosa bacteria was performed as a modified version
of previously described protocols (4, 8). Overnight cultures of P. aeruginosa were
washed twice in 1 ml serum-free HBSS and resuspended in 10 ml serum-free
HBSS. Bacterial concentrations were determined based on estimated 1  109
CFU/ml saturation levels. Naïve C57BL/6 mice were treated with 150 g lipo-
polysaccharide (Sigma) in PBS via tracheobronchial aspiration and were subse-
quently sacrificed 3 days later. The lungs were lavaged with 800 l of PBS with
5 mM EDTA. The bronchoalveolar lavage (BAL) fluid was centrifuged, and
pelleted lung cells were washed twice in 400 l serum-free HBSS before being
incubated with the indicated bacteria at an MOI of 10 for 45 min at 37°C. For
the gentamicin protection assay, alveolar phagocytes and bacteria were subse-
quently treated as described above for in vitro gentamicin protection assays.
Alternatively, alveolar phagocytes were coincubated with GFP-expressing bac-
teria for 45 min at 37°C. Cells were washed twice in serum-free HBSS and
resuspended in 250 l HBSS. Bacterial association with lung phagocytes was
determined via FACS analysis as described previously.
In vivo bacterial uptake assay. Live P. aeruginosa bacteria (5 106 or bacterial
numbers as indicated) either were injected intraperitoneally or were oropharyn-
geally aspirated into C57BL/6 mice. Mice were sacrificed 1 h postinjection, and
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peritoneal or BAL fluid lavages, respectively, were collected. Cells were pelleted,
washed twice in serum-free HBSS, and resuspended in 750 l of HBSS. Five
hundred microliters of each suspension was incubated in the presence of genta-
micin for 20 min at 37°C to kill noninternalized bacteria. Cells were washed twice
in serum-free HBSS and resuspended in 500 l 0.1% Triton X-100 in PBS.
Fifteen microliters of resuspended cells/bacteria was plated on Pseudomonas
isolation agar plates and incubated overnight at 37°C. Colonies were counted the
following morning, and CFU were calculated based on fraction of total sample
plated. For peritoneal in vivo phagocytosis studies, analyses of total cell numbers
and phenotypes were done in parallel. Total cell numbers harvested from peri-
toneal lavage samples were quantified using trypan blue staining and manual cell
counts of viable cells using a hemacytometer.
Data and statistical analyses. Sample sizes for each experiment varied and are
noted in the text. For all graphs, means and standard deviations are shown. As
indicated, one-way analysis of variance (ANOVA) with Tukey’s multiple com-
parison posttest or unpaired Student’s t test analysis was performed to assess
statistical significance of the data. In the figures, statistical significance is repre-
sented by an asterisk and indicates P  0.05.
RESULTS
P. aeruginosa strains lacking a flagellum or flagellar stator
proteins are impaired in swimming motility. In these studies,
a variety of P. aeruginosa mutants were used to assess and
quantitatively compare the effect of either loss of the flagellum
or flagellar function on the phagocytic recognition of these
bacteria by immune cells (Table 1). PA14 is a nonmucoid
wild-type P. aeruginosa clinical isolate and is the parental strain
for all of the isogenic mutants described in these studies (16,
20). Two mutants (pilB and pilG) defective for type IV pilus
expression and function were used as controls as strains that
are impaired in twitching motility but are fully competent at
swimming motility. Two different mutations (flgK, which codes
for the hook-filament junction protein, and fliN, which codes
for a subunit of the flagellar rotor complex) that are pheno-
typically impaired in proper flagellum expression were used, as
well as a quadruple mutant for four flagellar stator proteins
(motAB motCD) which results in intact flagellum expression
but nonfunctional swimming motility (26, 27). To confirm the
swimming motility phenotype of the mutant strains analyzed,
we performed a standard bacterial swimming assay whereby
liquid bacterial cultures are inoculated by stabbing puncture
into 0.3% agar plates (see Fig. S1 in the supplemental mate-
rial). Zones surrounding the point of inoculation were evalu-
ated as an indication of swimming motility (27). In accordance
with previous results, we observed complete lack of swimming
motility in the flagellum-deficient mutants and the stator-defi-
cient mutant while we observed a swimming phenotype in the
parental PA14 strain and the two pilus-deficient mutant strains
(Fig. S1) (26, 27).
Swimming-deficient P. aeruginosa strains are resistant to
phagocytosis by BMDCs in vitro. To evaluate the effect of loss
of bacterial motility on phagocyte recognition, we transformed
parental PA14 as well as flagellum-deficient flgK and fliN mu-
tants, the motAB motCD flagellar stator protein knockout,
and the pilus-deficient pilG mutant with a GFP expression
construct to allow FACS-based analysis of phagocyte-bacte-
rium interactions. The intensity of GFP fluorescence emitted
by our transformed strains did not vary significantly among the
strains (see Fig. S2 in the supplemental material), allowing us
to compare binding and uptake of these different strains di-
rectly in relation to each other. Using fluorescence as a quan-
titative indicator of bacterial association with BMDCs, we ob-
served a marked and significant reduction in the ability of
BMDCs to associate with flagellum-deficient strains (flgK and
fliN) compared to the parental PA14 bacteria (Fig. 1A and D),
though the pilus-deficient mutant (pilG) associated with the
BMDCs at levels comparable to those for the WT (Fig. 1A).
To more rigorously assess the differential phenotypes observed
with the GFP-expressing bacteria, we utilized a gentamicin
protection assay to specifically and quantitatively assess in vitro
phagocytosis of the respective bacterial strains. Both flagellum-
deficient strains exhibited a dramatic 100-fold reduction in
their phagocytic recognition by BMDCs in vitro compared to
the parental PA14 strain (Fig. 1B). To verify that this 100-fold
variance was not due to intracellular killing of P. aeruginosa, we
measured the intracellular killing rate of phagocytosed PA14.
Approximately 50% of ingested PA14 bacteria were killed
after 2 h of incubation with BMDCs, indicating that the 100-
fold differential in phagocytosis observed in a shorter duration
(45 min) is not within the margin of the killing rate (Fig. 2C).
With the use of both assays, we next tested if phagocyte
recognition and engulfment of P. aeruginosa were dependent
on a fully assembled flagellum by coincubating BMDCs with
the motAB motCD flagellar stator mutant and assaying via
flow cytometry and gentamicin protection. The motAB
motCD mutant was substantially and significantly reduced in
both its overall association (FACS assay [Fig. 1C, left]) and
subsequent engulfment (gentamicin protection assay [Fig. 1C,
right]) by BMDCs, similarly to the flgK and fliN mutants (com-
pare Fig. 1A and B with C). These results were then confirmed
by fluorescence microscopy, which similarly demonstrated the
dramatic deficit in the association of swimming-defective but
flagellum-expressing P. aeruginosa with BMDCs in vitro (Fig.
1E). This deficit was not due to observable differences in total
flagellar expression between the motAB motCD mutant and
the parental wild type as detected by Coomassie blue staining
and Western blot analysis (Fig. 2A), and in biochemical con-
firmation of a previous report utilizing microscopy (27), we
demonstrate that the motAB motCD mutant has an intact
extracellular flagellum (Fig. 2B). The observation that the
motAB motCD mutant, but not the pilG mutant, recapitu-
lates the dramatic phagocytic deficit seen for the flagellum-
deficient strains demonstrates that the resistance to phagocy-
tosis by these strains is not due to loss of an intact flagellum or
pili but the loss of functional flagellum-based motility. Addi-
tionally, this deficit is specific to flagellum-based swimming
TABLE 1. P. aeruginosa genetic mutants used in these studies
PA14 mutanta WT function ofgene product
Mutant phenotype for
bacterial motility




pilG mutant Pilus transcription factor Lacks pili, twitch
defective
flgK mutant Flagellar hook protein No flagellum,
swimming defective






Flagellar stator proteins Flagellum intact,
swimming defective
a PA14 is a nonmucoid WT clinical isolate.
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motility, since loss of pilus-based twitching motility did not
confer measurable phagocytic evasion.
P. aeruginosa mutants deficient for flagellum or flagellar
stator proteins are resistant to phagocytosis by human mac-
rophages in vitro. To evaluate whether swimming-defective P.
aeruginosa strains were also resistant to phagocytosis by human
cells, we generated in vitro peripheral blood mononuclear cell-
derived human macrophages to assay them by gentamicin pro-
tection assay for the relative phagocytic uptake of PA14 and its
isogenic pilB, pilG, flgK, fliN, and motAB motCD mutants
(Fig. 3). The results with human macrophages recapitulated
our data with murine BMDCs, whereby we observed a 30- to
100-fold impairment for the phagocytic recognition of swim-
ming-defective P. aeruginosa strains by in vitro-cultured human
macrophages compared to recognition of the wild-type paren-
tal bacterial strain (Fig. 3). The recapitulation of the murine
FIG. 1. P. aeruginosa mutants deficient for flagellum or flagellar stator proteins are resistant to phagocytosis by BMDCs in vitro. (A) C57BL/6
BMDCs were analyzed by FACS for relative association with GFP-transformed PA14, the pilus-deficient pilG mutant, or the flagellum-deficient
flgK and fliN mutants. (B) C57BL/6 BMDCs were assayed by gentamicin protection assay for relative phagocytic uptake of PA14 or flagellum-
deficient flgK and fliN mutants. The graph is plotted on a logarithmic scale. (C) FACS analysis (left) and gentamicin protection assay (right) of
C57BL/6 BMDCs coincubated with either WT PA14 or the motAB motCD flagellar stator mutant. (D) FACS histogram of total BMDC cellular
association with GFP-transformed P. aeruginosa strains after 45 min of coincubation. (E) Fluorescence microscopy of RFP-expressing BMDCs
coincubated with GFP-transformed PA14 or the motAB motCD mutant viewed with DIC overlay at 65 magnification. For all graphs,
phagocytic uptake levels were normalized as percentages of the mean WT phagocytosis. For all genotypes, n is 9; means, standard deviations,
and statistical significance (asterisks) are shown.
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data with human macrophages indicates that the loss of mo-
tility by P. aeruginosa bacteria is likely a universal evasion
strategy from phagocytosis by immune cells that spans multiple
cell types and species.
Loss of MyD88 signaling fails to recapitulate the phagocytic
deficit for a flagellum-deficient P. aeruginosa strain. Our data
with the motAB motCD P. aeruginosa strain indicated that
the deficit for flagellum-deficient strains is not an intrinsic
function of lack of flagellum expression itself or the loss of
flagellum-mediated activation of immune cells. To test this
hypothesis more stringently, we generated BMDCs from
MyD88-deficient (MyD88/) mice to determine if loss of
MyD88 signaling recapitulates the phagocytic deficit observed
for flagellum-deficient bacteria. We analyzed the relative as-
sociation of the GFP-expressing wild-type PA14, flgK, and
motAB motCD strains with WT or MyD88/ BMDCs in
parallel. Loss of MyD88 signaling did not change the relative
level of bacterial association with BMDCs (Fig. 4A). Further-
more, WT and MyD88/ BMDCs quantitatively assayed in
parallel for in vitro phagocytosis of wild-type or swimming-
defective P. aeruginosa supported the FACS analysis in that
loss of MyD88 signaling did not recapitulate the phagocytic
deficit seen with flgK and motAB motCD bacteria (Fig. 4B).
These results strongly support the idea that the phagocytic
deficit is independent of Toll-like receptor (TLR)/MyD88 sig-
naling during immune recognition of flagellum-deficient bac-
teria.
Loss of motility is sufficient to confer P. aeruginosa phago-
cytic resistance to primary peritoneal and alveolar murine
cells ex vivo. Having identified a deficit for the phagocytosis of
stator protein-deficient P. aeruginosa strains by murine BMDCs
and human cultured macrophages in vitro, we next tested
whether or not this observation could be recapitulated by pri-
mary cells ex vivo. Peritoneal phagocytes were harvested and
incubated with the various GFP-transformed bacterial strains,
and cellular association with the bacteria was analyzed by
FACS (Fig. 5A). Peritoneal phagocytes were also assayed for
their ability to phagocytose bacteria, assessed by gentamicin
protection (Fig. 5B). Consistent with our data derived from in
vitro-cultured cells, nonmotile P. aeruginosa strains were dra-
matically resistant to phagocytosis by ex vivo primary perito-
neal macrophages. As a control to assess whether this massive
phagocytic differential was merely reflective of a cell surface
binding deficit, we measured cell surface binding of bacteria to
murine peritoneal macrophages pretreated with cytochalasin
D to inhibit phagocytic uptake. Cytochalasin D treatment of P.
aeruginosa did not alter its motility (data not shown). No sta-
tistical difference in P. aeruginosa cell surface binding was
observed among the bacterial genotypes (see Fig. S3 in the
supplemental material); this is in direct contrast to parallel
association experiments using untreated, phagocytically com-
petent macrophages (Fig. 5A). These data support the idea
that it is the evasion of phagocytic engulfment and not initial
bacterium-phagocyte contact that provides for the phagocytic
resistance phenotype of nonmotile P. aeruginosa.
FIG. 2. Phagocytic resistance of nonswimming P. aeruginosa is not
due to bactericidal activity or differential flagellar expression. (A) WT
PA14 (PA14) and the motAB motCD (mot) strain express similar
total levels of flagellin as assessed by Western analysis for the FliC
protein (right). Coomassie blue staining of parallel lanes is shown as a
control for protein load (left). (B) To confirm that the motAB
motCD mutant strain has intact extracellular flagella, the flagella
were mechanically sheared from the bacteria and assessed by Coomas-
sie blue staining (left) and Western analysis (right). (C) The BMDC
killing rate of P. aeruginosa was assayed by gentamicin protection
assay. Following a 1-h coincubation of PA14 with BMDCs, gentamicin
was added, and at the indicated time points following gentamicin
addition, aliquots were harvested and lysed to assess the death of
internalized bacteria over the course of the assay. CFU were plotted
relative to initial recovery. For each time point, n is 6; standard
deviations are shown.
FIG. 3. P. aeruginosa mutants deficient for flagellum or flagellar
motor proteins are resistant to phagocytosis by human macrophages in
vitro. Peripheral blood mononuclear cell (PBMC)-derived human mac-
rophages were cultured and assayed by gentamicin protection assay for
relative in vitro uptake of PA14, pilus-deficient pilB and pilG mutants,
flagellum-deficient flgK and fliN mutants, and the flagellar stator pro-
tein-deficient motAB motCD mutant. Phagocytic uptake levels were
normalized as percentages of the mean WT phagocytosis. Statistical
significance (P  0.05) of differences from wild-type levels is indicated
(asterisks). Graphs are plotted on a log scale. For all genotypes, n is
9; means and standard deviations are shown.
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The lungs are a major site of clinical infection by P. aerugi-
nosa (14, 21), and the prevalence of pulmonary P. auruginosa
isolates lacking motility correlates with poorer clinical condi-
tion in CF patients (12). Therefore, to address whether our
previous results extended to pulmonary cells, we assayed bac-
terial association and phagocytosis by primary lung phagocytes
ex vivo. We harvested murine lung cells by bronchial lavage and
assessed phagocyte association with GFP-expressing bacteria
by FACS analysis (Fig. 5C) and assayed for bacterial uptake by
gentamicin protection assay (Fig. 5D). In these assays, flagel-
lum-deficient and stator protein-deficient P. aeruginosa strains
were highly resistant to phagocytosis and overall association
with ex vivo alveolar cells. These findings demonstrate that the
loss of bacterial motility by P. aeruginosa confers resistance to
phagocytosis by multiple types of primary murine immune
cells.
Stator protein-deficient P. aeruginosa strains are resistant
to phagocytosis in vivo. Having determined that loss of motility
protects P. aeruginosa from phagocytosis in vitro and ex vivo, we
next tested the in vivo relevance of our findings. To address
whether loss of motility in P. aeruginosa enables immune eva-
sion during infection of a host organism, we determined the
relative clearance of the PA14, flgK, and motAB motCD
bacterial strains by both peritoneal and pulmonary phagocytes
in vivo. With the use of a previously described in vivo genta-
micin protection assay (2), we observed a dramatic 10-fold
reduction in the ability of peritoneal phagocytes to ingest flgK
and motAB motCD mutants in vivo compared to uptake of
the parental PA14 strain (Fig. 6A). The differences in the
phagocytosis of the various bacterial strains were not due to
differential recruitment of cells to the peritoneal cavity during
the assay, since quantification of total peritoneal cells from
treated mice showed no discrepancy in total peritoneal cell
numbers between mice injected with the parental P. aeruginosa
strain and mice injected with the mutant P. aeruginosa strains
(Fig. 6B, bottom). Extending these findings, and with direct
clinical relevance to P. aeruginosa colonization of the lung, we
assessed the relative clearance of the PA14 and motAB
motCD bacterial strains by pulmonary phagocytes in vivo.
Consistent with our findings with peritoneal phagocytes, lung
phagocytes ingested motile PA14 10-fold better than did non-
motile PA14 (Fig. 6B, top). From these results, we conclude
that downregulation of motility, independent of structural loss
of flagella, by P. aeruginosa confers a dramatic resistance to
recognition by the host immune system in vivo and that this
provides a mechanism for immune evasion.
DISCUSSION
Pseudomonas aeruginosa is an opportunistic Gram-negative
pathogenic bacterium that poses a significant clinical concern
for immunocompromised individuals (9, 13, 14, 21). Two
prominent clinical correlations that have been identified in CF
patients are a strong positive correlation between the extent of
the P. aeruginosa infection and the severity of the prognosis for
the patient (12, 17) and a marked phenotypic shift toward the
loss of bacterial motility and downregulation of flagellum ex-
pression that correlates with the severity of CF disease (12, 17).
Therefore, there is considerable interest in understanding the
basis for the latter phenotypic observation, especially in rela-
tion to the advantage that it may confer on the bacteria and,
consequently, how we may more effectively treat the infection.
Previous reports have shown that loss of flagellar expression
in clinical bacterial isolates results in dramatic decreases in
nonopsonic phagocytic recognition by murine and human mac-
rophages in vitro (17, 18). Other reports have indicated that the
flagellum itself, and not the loss of bacterial motility, is the
primary determinant in controlling the host immune response
to P. aeruginosa (5). In these studies we have utilized a bacte-
rial and mammalian genetic approach to show that P. aerugi-
nosa strains that are defective for swimming motility are resis-
tant to phagocytosis in vitro and in vivo. Furthermore, we
demonstrate that this resistance to phagocytosis is independent
of flagellum expression and not dependent on MyD88 signal-
ing, in response to these bacteria. Our results indicate that it is
the functional loss of flagellum-mediated swimming motility in
P. aeruginosa that confers phagocytic resistance on these bac-
teria. These data are the first demonstration that the loss of
flagellar function, not the loss of the flagellum apparatus as an
activation or association ligand, is responsible for conferring
resistance to phagocytosis and that this phenotype has an im-
portant role in immune evasion by P. aeruginosa of both mouse
and human immune cells.
FIG. 4. The phagocytic deficiency for nonmotile P. aeruginosa
strains is independent of MyD88 signaling. (A) WT or MyD88/
BMDCs were assayed for relative in vitro cellular association of GFP-
PA14, GFP-flgK, or GFP-motAB motCD P. aeruginosa strains by
FACS analysis. Data are represented as the mean fluorescence inten-
sity (MFI) of each experimental group. (B) WT or MyD88/ BMDCs
were assayed for in vitro phagocytosis of PA14 or flgK or motAB
motCD P. aeruginosa strains by gentamicin protection assay. Phago-
cytic uptake levels were normalized as percentages of mean WT PA14
phagocytosis. The graph is plotted on a logarithmic scale. For all
genotypes, n is 6 and means, standard deviations, and statistical
significance (asterisks) are shown.
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Based on the observations that P. aeruginosa tends to down-
regulate flagellar gene expression and functional motility in CF
patients, it has been proposed that P. aeruginosa undergoes
these phenotypic changes as part of an immune evasion strat-
egy to avoid detection by phagocytic and cell-activating recep-
tors during chronic infections (12, 17). Furthermore, nonop-
sonic phagocytosis of P. aeruginosa has been reported to
require the expression of an intact flagellum, as flagellum-
deficient bacteria are reported to be resistant to phagocytosis
by murine and human macrophages in vitro (18). The motAB
motCD strain used in these studies is deficient for four stator
genes which comprise the stationary components of the P.
aeruginosa flagellar motor (27). In this strain, flagellar struc-
tures are intact on the surface of the bacteria but are not
functional and thus these bacteria are impaired in swimming
motility (27). Based on previous electron micrograph studies
and our confirmatory biochemical studies here, the flagellar
structure in the motAB motCD mutant is intact and does
not appear to be different from its wild-type counterpart (27).
By demonstrating that the motAB motCD strain is equally
as resistant to phagocytosis as the flagellum-deficient strains,
we conclude that the flagellum itself is not a critical ligand for
nonopsonic phagocytosis of P. aeruginosa in our experimental
system. Intriguingly, a previous report found that loss of the
stator genes motAB in a different human clinical P. aeruginosa
isolate resulted in resistance to phagocytosis by macrophages
in vitro (24). However, this did not affect measurable motility
and the authors noted that the parental strain used for their
studies exhibited an abnormal phenotype which possibly could
confound the interpretation of the data (24). In the PA14 P.
aeruginosa strain used in our studies, only loss of all four
bacterial stator proteins (motAB motCD) results in swim-
ming motility defects under standard experimental conditions
(27) and the isogenic motAB PA14 mutant did not recapitu-
late the phagocytic defect observed in the motAB motCD
mutant (data not shown).
TLR5 has been recognized as a major pattern recognition
receptor (PRR) in innate immune cells, binding bacterial
flagellin and activating the MyD88 cell signaling pathway (10,
25). We observed only a minor deficit for P. aeruginosa phago-
cytosis in MyD88/ BMDCs that did not recapitulate the
dramatic deficit seen for phagocytic recognition of flagellum-
deficient bacteria. Similarly, bacterial association with
MyD88/ BMDCs was not any lower than that with WT
BMDCs. These findings are particularly relevant since previ-
ously published hypotheses have argued that flagellum-defi-
cient bacteria escape immune detection primarily through the
loss of flagellum-mediated immune activation of TLR5 (5, 17,
18). Because activation via TLR5 is MyD88 dependent, we
believe that it is not a major contributor in the phagocytic
resistance phenomenon observed in the nonmotile PA14 mu-
tants. This is supported by similar degrees of phagocytic resis-
FIG. 5. Motor protein-deficient P. aeruginosa strains are resistant to phagocytosis by ex vivo primary phagocytic cells from the peritoneum and
the lung. (A) C57BL/6 peritoneal exudate cells were harvested by lavage and assayed by FACS ex vivo for relative cellular association with the
GFP-expressing bacterial strains indicated. MFI, mean fluorescence intensity. (B) Peritoneal phagocytes were assayed for relative phagocytosis of
WT PA14, flgK, and motAB motCD bacteria by gentamicin protection assay. (C) C57BL/6 lung phagocytes were harvested via bronchoalveolar
lavage and subsequently assayed by FACS ex vivo for relative cellular association with GFP-transformed bacteria as indicated. (D) Lung phagocytes
were assayed by gentamicin protection assay ex vivo for relative uptake of WT, flagellum-deficient mutant flgK, and flagellar motor protein-deficient
mutant motAB motCD bacteria. For all graphs, n is 4 and means, standard deviations, and statistical significance (asterisks) are shown.
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tance in both flagellated and nonflagellated nonmotile strains.
However, it is reasonable to suggest that TLR5 and other
MyD88-dependent PRRs likely do play a role in other aspects
of the overall immune response to PA14 infection. Indeed, it
has been demonstrated with an alternative P. aeruginosa strain
that the TLR5-flagellin interaction is sufficient to activate al-
veolar macrophage upregulation of cytokine production (5).
Additionally, we have previously reported that cytokine re-
sponses to bacterial challenge are not necessarily directly cou-
pled to the phagocytosis of those bacteria (2). Overall, it is now
clear that effective bacterial clearance of nonopsonized PA14
via phagocytosis hinges on motility-based factors outside of
simple recognition of flagellin as a stimulating ligand.
In summary, our data demonstrate that loss of swimming
motility in P. aeruginosa bacteria results in dramatic resistance
to phagocytic recognition by innate immune cells in vitro and in
vivo. This phagocytic resistance was observed for both mouse
and human cells and was not due to the specific loss of flagellar
expression, since bacteria that expressed nonfunctional flagella
were able to recapitulate the same phagocytic resistance ex-
hibited by flagellum-deficient bacteria. Furthermore, genetic
deletion of MyD88 in phagocytic cells was not able to recapit-
ulate the defect for phagocytosis of flagellum-deficient bacte-
ria, demonstrating that loss of flagellum-mediated TLR5 sig-
naling is not responsible for the impaired phagocytosis of
flagellum-deficient P. aeruginosa bacteria. We found that mo-
tility-deficient P. aeruginosa strains are resistant to phagocyto-
sis by both human and mouse phagocytes in vitro, as well as
primary mouse cells ex vivo and in vivo. These data provide new
insights into important clinical observations about P. aerugi-
nosa and the loss of bacterial motility and are the first dem-
onstration that P. aeruginosa strains defective for swimming
motility are resistant to phagocytosis in vivo. These findings
provide an important new understanding of the immunological
advantage in vivo for the loss of motility by P. aeruginosa during
chronic infections.
ACKNOWLEDGMENTS
We thank Shizuo Akira (Osaka University) and Paul Guyre, Harry
Higgs, and J. Ma Collins (Dartmouth) for reagents; Julie Acker and
Ryan Collins for technical assistance; the Dartmouth Medical School
FACS and microscopy core facilities; and Matt Wargo, Laurie Whit-
taker, and Jenna Allard (UVM) for technical advice.
This research was supported by RO1 AI067405 and a CF Founda-
tion RDP training grant (B.B.) and NIH training grants T32 AI07363
(E.A.) and NIGMS GM008704 (R.R.L.).
REFERENCES
1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami,
K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene
results in loss of IL-1- and IL-18-mediated function. Immunity 9:143–150.
2. Amiel, E., J. L. Acker, R. M. Collins, and B. Berwin. 2009. Uncoupling
scavenger receptor A-mediated phagocytosis of bacteria from endotoxic
shock resistance. Infect. Immun. 77:4567–4573.
3. Amiel, E., A. Alonso, S. Uematsu, S. Akira, M. E. Poynter, and B. Berwin.
2009. Pivotal advance: Toll-like receptor regulation of scavenger receptor-
A-mediated phagocytosis. J. Leukoc. Biol. 85:595–605.
4. Amiel, E., S. Nicholson-Dykstra, J. J. Walters, H. Higgs, and B. Berwin.
2007. Scavenger receptor-A functions in phagocytosis of E. coli by bone
marrow dendritic cells. Exp. Cell Res. 313:1438–1448.
5. Balloy, V., A. Verma, S. Kuravi, M. Si-Tahar, M. Chignard, and R. Ramphal.
2007. The role of flagellin versus motility in acute lung disease caused by
Pseudomonas aeruginosa. J. Infect. Dis. 196:289–296.
6. Bloemberg, G. V., G. A. O’Toole, B. J. Lugtenberg, and R. Kolter. 1997.
Green fluorescent protein as a marker for Pseudomonas spp. Appl. Environ.
Microbiol. 63:4543–4551.
7. Braun, T. F., S. Poulson, J. B. Gully, J. C. Empey, S. Van Way, A. Putnam,
and D. F. Blair. 1999. Function of proline residues of MotA in torque
generation by the flagellar motor of Escherichia coli. J. Bacteriol. 181:3542–
3551.
8. Duncan, M. J., G. Li, J. S. Shin, J. L. Carson, and S. N. Abraham. 2004.
Bacterial penetration of bladder epithelium through lipid rafts. J. Biol.
Chem. 279:18944–18951.
9. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and
management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit.
Care Med. 168:918–951.
FIG. 6. Flagellum-deficient and stator protein-deficient P. aerugi-
nosa strains are resistant to phagocytosis in vivo. (A) (Top) An in vivo
gentamicin protection assay was used to determine relative uptake of
PA14, flgK, and motAB motCD bacterial strains by peritoneal
phagocytes. Phagocytic uptake levels were normalized as percentages
of the mean WT phagocytosis levels. (Bottom) Total peritoneal cells
were quantified from lavage samples of mice treated with PA14, flgK,
or motAB motCD bacteria, to control for differential immune cell
recruitment by the different bacterial strains. (B) Gentamicin protec-
tion assay results following in vivo oropharyngeal aspiration of WT or
motAB motCD PA14 are consistent with the data shown in panel A,
with nonmotile PA14 being 10-fold more resistant to phagocytosis
than motile PA14. Individual data points (mice), means, and statistical
significance (asterisks) are shown.
2944 AMIEL ET AL. INFECT. IMMUN.
10. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett,
J. K. Eng., S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate
immune response to bacterial flagellin is mediated by Toll-like receptor 5.
Nature 410:1099–1103.
11. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S.
Muramatsu, and R. M. Steinman. 1993. Granulocytes, macrophages, and
dendritic cells arise from a common major histocompatibility complex class
II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. U. S. A.
90:3038–3042.
12. Luzar, M. A., M. J. Thomassen, and T. C. Montie. 1985. Flagella and motility
alterations in Pseudomonas aeruginosa strains from patients with cystic
fibrosis: relationship to patient clinical condition. Infect. Immun. 50:577–582.
13. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2000. Establishment of Pseudo-
monas aeruginosa infection: lessons from a versatile opportunist. Microbes
Infect. 2:1051–1060.
14. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated
with cystic fibrosis. Clin. Microbiol. Rev. 15:194–222.
15. MacFerrin, K. D., M. P. Terranova, S. L. Schreiber, and G. L. Verdine. 1990.
Overproduction and dissection of proteins by the expression-cassette poly-
merase chain reaction. Proc. Natl. Acad. Sci. U. S. A. 87:1937–1941.
16. Mahajan-Miklos, S., M. W. Tan, L. G. Rahme, and F. M. Ausubel. 1999.
Molecular mechanisms of bacterial virulence elucidated using a Pseudomo-
nas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96:47–56.
17. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility
and phagocytic resistance of Pseudomonas aeruginosa isolates from chron-
ically colonized patients with cystic fibrosis. Infect. Immun. 62:596–605.
18. Mahenthiralingam, E., and D. P. Speert. 1995. Nonopsonic phagocytosis of
Pseudomonas aeruginosa by macrophages and polymorphonuclear leuko-
cytes requires the presence of the bacterial flagellum. Infect. Immun. 63:
4519–4523.
19. Montie, T. C., R. C. Craven, and I. A. Holder. 1982. Flagellar preparations
from Pseudomonas aeruginosa: isolation and characterization. Infect. Im-
mun. 35:281–288.
20. Rahme, L. G., E. J. Stevens, S. F. Wolfort, J. Shao, R. G. Tompkins, and
F. M. Ausubel. 1995. Common virulence factors for bacterial pathogenicity in
plants and animals. Science 268:1899–1902.
21. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005.
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J.
Respir. Crit. Care Med. 171:1209–1223.
22. Sauer, K., and A. K. Camper. 2001. Characterization of phenotypic changes
in Pseudomonas putida in response to surface-associated growth. J. Bacte-
riol. 183:6579–6589.
23. Semmler, A. B., C. B. Whitchurch, and J. S. Mattick. 1999. A re-examination
of twitching motility in Pseudomonas aeruginosa. Microbiology 145:2863–
2873.
24. Simpson, D. A., and D. P. Speert. 2000. RpmA is required for nonopsonic
phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 68:2493–2502.
25. Smith, K. D., and A. Ozinsky. 2002. Toll-like receptor-5 and the innate
immune response to bacterial flagellin. Curr. Top. Microbiol. Immunol.
270:93–108.
26. Toutain, C. M., N. C. Caizza, M. E. Zegans, and G. A. O’Toole. 2007. Roles
for flagellar stators in biofilm formation by Pseudomonas aeruginosa. Res.
Microbiol. 158:471–477.
27. Toutain, C. M., M. E. Zegans, and G. A. O’Toole. 2005. Evidence for two
flagellar stators and their role in the motility of Pseudomonas aeruginosa. J.
Bacteriol. 187:771–777.
Editor: A. Camilli
VOL. 78, 2010 PSEUDOMONAS AERUGINOSA EVASION OF PHAGOCYTOSIS 2945
